A new study has focused on the impact of weight loss injections on taste perception in individuals with obesity. The study involved 30 women with polycystic ovary syndrome, a condition that often leads to obesity. The women received an Ozampic injection once a week for 16 weeks while a control group did not receive any treatment.
The study found that after 16 weeks, the women who received the Ozampic injection showed an increase in taste sensitivity and changes in brain activity compared to the control group. The injection seemed to affect brain regions associated with reward and taste perception, suggesting a potential mechanism for how weight loss injections may impact taste perception in individuals with obesity.
While the study focused on Ozampic, a higher-dose injection called Vigovi has recently been introduced in Israel for weight loss. However, concerns about the high cost of the injection have led some users to hesitate switching from Ozampic to Vigovi. The Ministry of Health has recommended prescribing Vigovi instead of Ozampic for weight loss, but uptake has been slow due to the price difference.
In conclusion, the study’s findings suggest that weight loss injections may influence taste sensitivity in individuals with obesity, offering new insights into the mechanisms behind these treatments. Further research is needed to understand the full impact of these injections on taste perception and weight loss outcomes.
